Access the right intelligence at a pricing that flexes as per your needs! - MarketNgage!

 

With MarketNgage, you can find the right market intelligence instantly. A one-stop-shop for all your disparate market intelligence needs. Visit MarketNgage today for exciting launch offers and introductory discounts.

 Subscribe and get started with free credits https://www.marketngage.com/

 #MarketNgage #marketresearch #marketanalysis #strategy #businessconsulting #FMI #TMR #FactMR #PMR

Global Homeopathy Products Market - Increasing Awareness about Herbal Medicines Drives Growth Across the Globe

Homeopathy is alternative medicine, which was established in Germany in the later part of the 18th century. It is based on the idea of ‘Law of Similars’. According to this principle, if a matter can produce symptoms in a healthy individual, it can treat similar symptoms in a sick individual. Homeopathic medicines are composed of natural substances in extremely diluted amounts for the treatment of a number of ailments. These medicines are prepared by repeatedly diluting and vigorous shaking of the original substance preparation in water and alcohol. Post dilution, the medicine is added to pillules or lactose tablets.

Request a Free PDF Brochure with Report Analysis: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13049

The global homeopathic products market is on the rise due to the increasing demand for homeopathy for the treatment of several diseases. According to the World Health Organization, homeopathy is the second largest medicine system displaying a growth rate of 20-25% each year. This is because homeopathy has reportedly proven to be effective for the treatment of several acute and chronic diseases. Though there is a lack of understanding of working of homeopathic medicines, these medicines are believed to be active and are curative.

The increasing participation of several new players is also leading to the growth of the global homeopathy products market. These players are focused on the utilization of new technologies for the development of more effective products.

North America is the largest regional market for homeopathy products due to several factors. These include increasing preference of individuals for natural and holistic medicine and favorable reimbursement policies for the same. Europe is the second-largest market for homeopathy products. In the U.K., homeopathy is fully recognized as a curative medical practice and is covered by public health insurance. Asia Pacific is emerging as a significant market for homeopathy products due to the rapid advancement of the healthcare industry in emerging economies and the revival of alternative medicine for fewer side-effects. According to a study carried out by the Associated Chambers of Commerce and Industry of India in 2011, the domestic homeopathy market is expected to reach new heights in the coming years.

Some of the leading players in the global homeopathy products market are Hahnemann Laboratories Inc., Natural Health Supply, SBL, Hyland’s Homeopathic, and Nelson & Co. Ltd.

Global Negative Pressure Wound Therapy Market to Touch US$2.9 bn by 2020, Increasing Incidence of Chronic Wounds Fuels Demand

Transparency Market Research (TMR) has recently published a study on the global negative pressure wound therapy (NPWT) market, according to which, the market is anticipated to rise at a healthy CAGR of 10.20% between 2014 and 2020.The research report, titled “Negative Pressure Wound Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” estimates this market to increase from a total value of US$1.5 bn in 2013 to US$2.9 bn by the end of the forecast period.

Free PDF Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1718

Negative pressure wound therapy is an advanced therapy that applies negative or sub-atmospheric pressure to a wound in a closed wound drainage system. The devices used in this therapy make use of a mechanical as well as an electrical suction pump to transfer negative pressure through connecting tubes to wound dressing kits to promote faster wound healing. These devices can be utilized for the treatment of pressure sores, traumatic wounds, surgical wounds, and chronic wounds such as venous stasis ulcers and diabetic foot ulcers.

According to the study, the NPWT market is likely to witness a robust rise in its valuation during the forecast period owing to the increasing incidence of acute and chronic wounds.The report has studied the global NPWT market on two fronts: Product and the region. Based on product, the market has been categorized into single-use NPWT devices and conventional NPWT devices. The conventional NPWT devices segment has been leading the overall market since the last decade. However, the single-use NPWT devices segment is projected to register a higher CAGR of approximately 17.0% over the forecast period.

The shift in preference of patients from conventional NPWT devices to single-use devices, on account of the convenience and the cost benefits offered by the latter, is likely to propel this market segment significantly in the coming years, notes the study.

Geographically, the report segments the worldwide NPWT market into Europe, North America, Asia Pacific, and the Rest of the World. North America emerged as the biggest regional market for NPWT in 2013. The increasing incidence of chronic diseases, rising awareness among patients regarding healthcare, and favorable reimbursement scenario have boosted this regional market.

In the same year, Europe acquired the second position in the global NPWT market on account of the augmented rate of transit accidents and increased incidence of chronic wounds.

Research Report: http://www.transparencymarketresearch.com/negative-pressure-wound-therapy.html

Though both the regional markets are projected to record healthy growth during the forecast period, they are likely to lose ground to Asia Pacific market for NPWT. The NPWT market in Asia Pacific is expected to gain from the strengthening economy, supportive government policies, and the soaring demand for technically advanced wound care products in the coming years, states the report.

Devon Medical Inc., Talley Group Ltd., Smith & Nephew plc, Prospera Technologies LLC, Molnlycke Health Care AB, Kinetic Concepts Inc., Genadyne Biotechnologies Inc., ConvaTec Inc., and ArjoHuntleigh International AB are the major international players in the negative pressure wound therapy market, reports the study.

Global Cell Culture Market: Growing Demand for Artificial Organs to Pave Way for Market’s Growth

The vendor landscape in the global cell culture market includes players such as VWR International LLC, Thermo Fisher Scientific Inc., GE Healthcare, Lonza Group Ltd., Becton, Dickinson & Co., Sigma-Aldrich Co. LLC., Corning Life Sciences B.V., EMD Millipore, PromoCell GmbH, and Wheaton Industries Inc. According to a TMR analyst, mergers and acquisitions among the key players are expected to strengthen the market in the coming years. 

Download Free PDF Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=405

Cell Culture Consumables Register Higher Demand than Serums and Reagents

The market players are registering increased demand for cell culture across the medical research sector. Cell cultures are being increasingly applied across drug screening and monitoring, disease diagnosis, biologic manufacturing, IVF technology, cancer research, and stem cell research. Increased investments by private medical organizations and government organizations have supported the growth of the global cell culture market. TMR states that among the cell culture consumables, cell culture media register the highest demand compared to serums and reagents. This is due to the key importance of the nature of the culture medium to the health of the cells.

3D Cell Culture to Define Future of Global Cell Culture Market

The growing demand for biopharmaceuticals and artificial organs, coupled with the emerging trend towards serum-free, customized and specialty media solutions is the primary factor contributing towards the growth of the global cell culture market. The increasing focus on stem cell research would further expand the scope of the market in future. TMR recommends that the focus on backward integration to conduct in-house research and sustaining pricing pressures amid a weak global economic scenario will open up significant opportunities for the market players.

However, ethical concern over the usage of animal sources in cell culture is one of the major restraints in the growth of the market. The usage of transgenic plants and animals, and stringent process controls will also impede the growth of the market in the years to come. “3D cell culture has the potential to serve as the future growth opportunity for the market and in vitro analysis.” a TMR analyst predicts.

Asia Pacific to Register Highest Demand for Cell Culture

TMR predicts that among the key regions in the global cell culture market, Asia Pacific will register the fastest growth during the period between 2014 and 2022. “The improvement in economic conditions of the developing countries in the Asia Pacific region such as China and India is anticipated to support the market’s growth,” the analyst states. In 2013, North America was the leading region in the market.

Browse Research Insights: http://www.transparencymarketresearch.com/cell-culture-market.html

TMR finds that the various opportunities in the global cell culture market will propel the expansion of the market at a CAGR of 7.1% during the period from 2014 to 2022. This would lead to an increase in the valuation of the market from US$6.1 bn in 2013 to US$11.3 bn in 2022.

Prevention-Better-than-Cure Sentiment to Help Ultraviolet Germicidal Irradiation Systems Sales Touch New High, says TMR

The key players holding the lion’s share in the global ultraviolet germicidal irradiation market are America Ultraviolet, GE Water & Process Technologies, and UltraViolet Devices, Inc. amongst others, TMR finds in a new report. The majority of these companies will focus on offering effective and cost-efficient products to tap the unmet needs in the overall market. For instance, GE Water & Process Technologies is adopting advanced H-technology to improve its line of products and services to gain a competitive edge in the overall vendor landscape. The global UVGI market will also witness a broader range of products in the coming years to appeal to a wider segment of consumers.

Download Free Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10826

Prevention of Diseases Augments UVGI Market

The noteworthy technological advancements in the UVGI systems have made them a popular choice for sterilization process in restaurants, air-conditioned offices, food joints, hospitals, and several manufacturing units. Consumers are opting for installing hi-tech UVGI systems in order to prevent the occurrence of dangerous airborne diseases, reducing the maintenance cost of HVAC, and mitigating the chances of microbial contamination through air vents.

The rising number of hospital-acquired infections (HAIs) is also driving the global UVI market. According to statistics published by the World Health Organization (WHO) in 2013, about seven patients out every 100 admitted in hospitals acquire HAIs. The global UVGI market will growth at an unprecedented rate against the backdrop of these factors.

Import-related Hurdles to Restrain Market

The biggest challenge faced by this market are the hurdles in developing countries to import UVGI systems. Furthermore, these countries also have a dearth of skilled labor that has the technical knowledge of installing and maintaining these systems. Therefore, the majority of the developing countries have to depend on outsourcing help, which increases the installation costs.

All of these factors are hampering the growth of the UVGI market in emerging economies. Global players are also suffering as several developing countries are formulating new policies to support local manufacturers. This shift in preference is setting a trend in countries of Latin America and Asia Pacific.

A TMR analyst states, “The global UVGI market does have a lineup of some lucrative opportunities such as the burgeoning demand from water purification and advanced packaging sector that are looking at ways to avert air and borne diseases.” The unfortunate reduction in sources of fresh water sources, water pollution, and air pollution have collectively created a demand for UVGI in the food and beverages packaging sectors.

According to TMR’s report, the opportunity in the global ultraviolet germicidal irradiation market was valued at US$168.4 mn in 2014. By the end of 2023, its valuation is anticipated to reach US$430.3 mn, rising at a CAGR of 10.9%between 2015 and 2023. The air disinfectant UVGI systems are expected to make a significant contribution to the growth of this market as its valuation will likely rise to US$375.2 mn by 2023.

The analysis of the market drivers and restraints in the global UVGI market is based on the findings of a report published by Transparency Market Research. The report is titled “Ultraviolet Germicidal Irradiation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2023.”

Telehealth Initiatives to Improve Efficiency and Quality of Medical Tourism

Over the past two decades, plenty of telehealth applications have been successfully implemented.

Applications such as the transfer of digital photos and patient records and the use of medical video endoscopes to monitor patients’ physical examination have demonstrated great results. For many players, the introduction of telehealth in the global medical tourism market has been a profitable strategy.

Telehealth improves the efficiency, customer service, and quality of medical tourism services via enhanced coordination of care between patients and care providers. According to Transparency Market Research (TMR), the global medical tourism market is expected to exhibit a 17.90% CAGR from 2013 to 2019. A rise in the elderly population and the rising number of uninsured people are some of the factors expected to propel the global medical tourism market.

For Technical Insights Avail PDF: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=900

TMR experts answers a few questions with respect to the global medical tourism market:

Q. How would the implementation of telehealth drive medical tourism?

A. The use of telehealth in medical tourism can offer many benefits. Telehealth improves the quality and process of pre-operative and post-operative care. It also helps control the baseline data remotely. Anesthesiologists can remotely perform the physical assessment of respiratory systems via teleconsultation.

Telehealth allows surgeons to manage follow-up care by connecting to primary care providers of patients. It also assures continuity in patient care by offering timely pre and post consultation.

Leading players and the new entrants operating in the global medical tourism market have started adopting telehealth services for bridging the gap between patients and doctors.

VoyagerMed, a New York-based medical care company, recently announced its plans to launch a telehealth initiative to connect patients from other countries to the U.S. physicians. The telehealth initiative is expected to allow patients to have real-time interaction with healthcare providers.

Q. How will telehealth help players in global medical tourism market to serve patients in the urban and rural areas?

A. As telehealth is being implemented by many healthcare service providers, it will improve the access to care in urban and rural environments to a great extent. People travel abroad from their home country to avail advanced medical care facilities. Telehealth helps healthcare providers to reach people living in rural and urban areas and provide healthcare facilities.

With telehealth, the medical tourism industry is being remade. For instance, millions of people travel to the U.S. to avail superior healthcare. Leading healthcare organizations in the U.S. have started using telehealth facilities to offer medical consultation to those who cannot afford to travel.

Q. What are the challenges faced by the hospitals using telehealth services?

Telehealth in medical tourism has certainly become a rising trend. However, healthcare organizations and hospitals using telehealth services need to consider a few challenges. Legal factors of every country can complicate the entire telehealth landscape. For instance, in the U.S., a telehealth doctor is transported to the patient’s country virtually. Thus, physicians, in order to offer their medical services, need to possess a valid license.

As telehealth services are new, rules and regulations regarding inter-nation telehealth practices are not fully developed. This can hamper the growth of the global medical tourism market.

Download Complete Report Sample: http://www.transparencymarketresearch.com/medical-tourism.html

Over the past few years, there have been vast improvements in telehealth technologies. Although there are a few technical, regulatory, legal, and organizational obstacles, they are manageable. Going forward, telehealth is expected to play a leading role in shaping the global medical tourism market.  

Global Medical Traction Devices Market Gains Momentum as Patients Increasingly Prefer Non-invasive Procedures

Transparency Market Research is compiling multiple research reports on the industry of medical devices, all replete with the latest market statistics and trends linked to them. “Medical Traction Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 – 2024” is one such report that follows up on medical traction devices and how their market is expected to shape itself in the coming years.

Request a Brochure Download for Free: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12230

In orthopedics, traction devices are mainly used to reset broken bones or muscles. The most common use of traction devices is to straighten the spine by applying mechanical pressure to it from outside the body. There are two generalized segments of device types in the global medical traction devices market: The ones intended for the skin and the ones intended for skeletal restructuring.

There are many types of devices present in the global medical traction devices market, and most of them are intended for children with congenital deformities or people who have suffered from spinal compression. For instance, a device such as the Milwaukee brace is used to straighten out a curved spine in children. Other types include Buck’s traction device and Bryant’s traction device.

One of the primary drivers for the growth of the global medical traction devices market is the high preference of patients for non-invasive treatment methods. A growing number of patients are opting for traction devices and even alternative medicine to avoid surgery and any invasive procedure. As a result, patients suffering from bone deformities, bone fractures, and muscle contracture are applying in greater numbers for medical traction devices instead of surgery.

Another factor promoting the growth of the global medical traction devices market is the growing geriatric population. A steady increase in the elderly numbers is key for the global medical traction devices market, as they are the most prone to musculoskeletal problems.

The global medical traction devices market also benefits from added interest shown by patients who suffer from chronic pain. These patients, who have handled the pain, the long lists of drugs, and the side effects related to these drugs, are always looking for alternatives to painkillers and surgical procedures. The global medical traction devices market can therefore find a high scope of growth in this sector.

In terms of device types, the global medical traction devices market contains devices such as the anatomotor. Arthrotonic stabilizers, and the DRX9000 spinal decompression machine.

The key players in the global medical traction devices market are VAX-D Medical Technologies, LLC, CERT Health Sciences, Spinal Designs International, Inc., SpineRx Technology, Medtronic, Inc., North American Medical (NAM) Corporation, STOLL Medizintechnik GmbH, RS Medical, and The Saunders Group, Inc.

Global Biodefense Market to Capitalize on Rising Threat of Bioterrorism

In the last few years, biodefense has emerged as a popular method to combat the potential negative effects of bioterrorism, which is spread by biological agents or deployed using biological weaponry. The rising threat of bioterrorism and the subsequent proliferation of disease surveillance missions have driven the market for biodefense around the world.

In its report, titled “Biodefense Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,” Transparency Market Research provides a comprehensive overview of the global market for biodefense. It covers aspects such as the market’s definition, segmentation based on various parameters, and factors impacting the market’s growth trajectory.

Bioterrorism refers to the deliberate release of biological agents such as viruses, bacteria, toxins, or germs, which may be naturally occurring or in modified forms, in order to disseminate infections or to cause illness or death. While these germs are often found in nature, bioterrorism makes them more virulent by enhancing their potential to spread infections or by making them drug-resistant. It is possible to disseminate these biological agents through air, water, food, or from person to person. At an initial stage, these infections can be hard to detect, since they do not show any symptoms in the first few hours or days. Biodefense has emerged as a potential solution to protect people against bioterrorism.

Biodefense is deployed in two ways. It is either used as defense against an attack on a civilian population or on a military target. Ensuring defense against attacks on civilian populations is primarily based on the detection of the infection and methods to minimize the casualties and loss of water or food.

Get a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=5369

The global market for biodefense is witnessing impressive growth prospects in response to the rising importance of disease surveillance to combat the looming threat of bioterrorism. The attack of September 11, 2001, in the U.S. was followed by the subsequent outbreak of spores, anthrax, and other severe ailments. These events exposed the vulnerability of human society to bioterrorism and made governments from across the world realize the importance of improving their public health scenario, to shorten the response time in the event of similar disasters that may occur in the future.

Funding to improve bioterrorism preparedness has enabled Public Health Service to expand the reach of their surveillance activities significantly and to effectively monitor the community’s health. Such recent incidents are substantially boosting the market for biodefense, which is poised to exhibit exponential growth between 2015 and 2023. Furthermore, the recent outbreak of Ebola, Zika, and the nuclear crisis in Japan are also expected to fuel demand from the biodefense market.

Regionally, North America led the global biodefense market, followed by Europe. North America boasts enhanced lab capabilities and has successfully implemented rapid health alert systems, which aid the expansion of the biodefense market in the region. However, Asia Pacific is likely to emerge as the most lucrative market for biodefense in the near future, with the region exhibiting a high adoption rate of analytical equipment and rapid development of the biotechnology industry. The Middle East and Latin America will also emerge as prospective markets for biodefense over the report’s forecast period.

Healthcare Industry to Grow due to Cutting-Edge Technologies Being Introduced By IT and Telecom Sectors

A new market research report by Transparency Market Research, titled “The Role of IT and Telecom in Healthcare Industry Analysis and Forecast 2015-2023”, presents an extensive study on the key roles of telecom and IT within the healthcare industry. The growth trends seen in the healthcare industry owing to IT and telecom playing major roles have also been illustrated in this study. The numerous opportunities, drivers, and inhibitors experienced by the healthcare industry in the forecast horizon have also been presented in this report. The growth of the industry has been estimated on the basis of revenue across various geographical segments. The competitive profiling of the prime players operating in the telecom and IT sectors and the various technologies introduced by them for the development of the healthcare industry are also a part of this study. Thus, the report provides a closer look on the healthcare industry, particularly from the perspective of the telecom and IT industry. 

Add caption

As per the report, IT supports the healthcare industry by handling a number of peripheral and core operations of the industry. The functions of IT range from patient data storage to patient health monitoring to the presentation of optimal therapies for patients. Various cutting-edge technologies such as SaaS, telecom-centric solutions, and cloud computing have been specifically developed for the healthcare industry. The advent of telecom has also resulted in healthcare providers leveraging their conventional medical care resources such as clinics, hospitals, and equipment across a broader remote patient base. In addition, telecom providers have fulfilled the rising demand from the healthcare industry for greater bandwidth, mobility solutions, and high-performance technologies. 

Get a Sample Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=99

Moving further, the report states that the development in telecommunications has also enabled remote patient monitoring as well as accurate methodologies for the treatment and diagnosis of medical conditions. This is why the quality of medical care is predicted to immensely improve in emerging economies in the coming years. Further, the report states that 24/7 monitoring is made possible by the implementation of telecom and IT in the healthcare industry. This has resulted in an increasing demand for telecommunications and IT products within the healthcare industry and this demand is poised to increase in forthcoming years, as per this study.

The report states that owing to rising usage of interconnected networks as well as electronic health records (EHR), collaboration will be seen amongst care teams, clinicians, and organizations for optimization of treatment resources in the healthcare industry. In the last section of the report, the healthcare industry has been segmented on the basis of geography into North America, Europe, Asia Pacific, and Rest of the World (RoW). Data regarding the performance of each regional segment is given in the report.

Biomaterials Market Research That Multiply your Investment!

In a latest research report published by Transparency Market Research (TMR) “Biomaterials Market for Implantable Devices - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, the global biomaterials market is forecasted to grow at a CAGR of 4.1% between 2013 and 2019. According to the report, the market is estimated to be valued at US$33,600 million by 2019, increasing from US$25,277.8 million in 2012. Biomaterials are fabricated from either synthetic or natural origin materials that are used for medical implants. Heart valves, dental implants, artificial hip joints, and intraocular lenses are some of the commonly used medical implants for which biocompabitility and safety needs to be guaranteed, since these implants come in close proximity to internal organs in the human body. Owing to such reasons it necessary that biomaterials are biocompatible, which means they should not interfere with the physiology and not cause any immunogenic reaction in the human body.

Growth Drivers and Opportunities 

According to the findings of this market research report, the biomaterials market for implantable

devices will find a remunerative consumer base in the aging population that is pushing up the demand for graft transplants and medical implants. The average life expectancy of humans is on the rise, and continues to increase in densely populated emerging countries. 

A growing incidence of diseases such as osteoporosis and arthritis will continue to propel the need for medical implants, which in turn utilize biomaterials. The focus remains on making implants and related procedures as comfortable and painless as possible among patients. 

Overview of segments and their growth prospects 

The report finds that as of 2012, metals as a biomaterial for implantable devices constituted the largest share within the global biomaterials market. The polymer biomaterials segment came a close second and continues to exhibit promising growth. TMR analysts predict that the polymers segment will witness the fastest growth within the biomaterials market for implantable devices between 2013 and 2019. 

According to the report, as of 2012, orthopedic applications were seen to hold a considerable share in the global biomaterials market for implantable devices because of a high number of knee and hip replacement procedures. In the near future, the biopolymers segment will receive impetus from the ophthalmic applications.

The report also finds that countries such as United States, Germany, Canada, France, Italy, U.K., and Spain are recording a high number of medical implant procedures, whereas the same remain sluggish in other regions. North America is the largest biomaterials market for implantable devices with Europe taking the second place globally. But the competition here remains cutthroat and this has prompted many players to venture into hitherto untapped markets in the Asia-Pacific region, such as Japan, China, South Korea, India, and Taiwan.

Request a Custom Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2384

Companies mentioned in the biomaterials market for implantable devices study

The report profiles prominent names in the global biomaterials market for implantable devices, such as: AdvanSource Biomaterials Corporation, Biomet, Inc., Celanese Corporation, Collagen Matrix, Inc., Ceradyne, Inc., DuPont, Evonik Industries AG, Royal DSM, Corbion Purac, and Invibio, Inc.

Pharmerging Market: BRIC Nations to Drive Market Growth during 2015-2023!

A robust revenue growth of the global pharmaceutical market is poised to break horizon from the pharmerging market. Sales growth in the matured markets such as the U.S., Canada, Western Europe, U.K., and Japan is expected to slow down owing to patent expirations followed by the prevalence of low-cost generics. Introduction of new molecular entities will only drive these shrinking (matured) markets in future. However, as research consumes long periods and huge costs, pharmaceutical multinationals are eyeing the pharmerging market to offset for their investments and sustain a modest growth in the global pharmaceutical market. 

IMS has defined pharmerging markets or countries as those having a per capita GDP threshold of USD 25,000 and more than USD one billion spending growth from 2012 to 2016. Thus includes 21 countries which are identified based on the IMS defined parameters coupled with the macroeconomic factors and respective pharmaceutical market forecasts. IMS estimates that these 21 pharmerging markets will add USD 187 billion in annual sales to the global pharmaceutical market between 2012 and 2017. This value represents two third of the global pharmaceutical market growth which will be an increase of global share from 23% in 2012 to 33% in 2017. The BRIC nations i.e. Brazil, Russia, Indian and China will lead the pharmerging market. 

IMS has classified the pharmerging markets into three categories as tier 1, tier 2 and tier 3 markets.

Tier 1 pharmerging market includes China which is the largest and fastest growing pharmaceutical market. It will be the largest pharmerging market supported by the growing healthcare spending by Chinese government, implementation of the four year plan (2012 – 2015) for the prevention and control chronic diseases and drug cost lowering measures. Tier 2 category includes India, Brazil and Russia. Pharmaceutical market in these countries is expected to be driven by rising government healthcare expenditure, increasing purchasing power of general population, roaring access to medicines, rising and aging population and growing burden of chronic diseases. Tier 3 category includes the rest 17 countries which is further differentiated into two groups based on the average pharmaceutical spend per capita.

The spending growth in the pharmerging market is expected to grow with a CAGR of 12% to 15% which will expedite the market growth in these countries. Moreover, the pharmerging market is witnessing an increase in mergers and acquisitions among multinationals, to seize best of the opportunities in these revenue driver markets. For instance, Abbott Laboratories acquired Piramal Healthcare in 2010 becoming a leader in the Indian Pharmaceutical Market. Besides, Eli Lilly expanded a strategic partnership with Chinese manufacturer Novast Laboratories Ltd. in 2011 to provide Chinese patients with high-quality generic medicines. Such activities are expected to grow further which will boost the pharmerging markets further in the near future. Moreover, apart from the inorganic route, multinationals are also growing through organic route by investing in these countries to establish their research or manufacturing facilities. Greenfield investment will prove to be a long term boon for these pharmerging countries. One of the biggest challenges faced by the multinationals in the pharmerging market is pricing pressure which impacts the profit margin of these companies. Big pharmaceutical companies need to lower their prices to compete in the local market. 

Future of Telemedicine - Key Trends and Forecast 2020

Telemedicine is the evolved format of traditional medicine that provides medical care to millions of individuals worldwide with the benefits of cost efficiency and convenience of location. The basic difference between traditional healthcare technology and telemedicine is the use of telecommunication technology to provide patients and medical practitioners the convenience of location, cost and time. With the advent of communication technology in medical sciences, telemedicine revolutionized the overall framework of healthcare. Patients were no longer subjected to travel or waiting periods and could seek medical attention at the comfort of their homes. This greatly changed the perception of medical practice, which is the major reason why telemedicine is currently considered synonymous with general medicine. Telemedicine involves the use of mobile communication technology and image/video transfer technology via the internet. The internet has provided the basis for information exchange, which is stored and maintained by the servers present at either hospitals or telemedicine service provider company at a nominal cost. 

Current Developments in the Global Telemedicine Market

At present, the global telemedicine technologies market is facing a number of challenges that it needs to overcome in order to ensure its high growth in the coming few years. Some of the major challenges hampering this market are the shortage of skilled and experienced professionals in remote areas and absence of consumer awareness about telemedicine technologies and their uses. Other major restraints suppressing the global telemedicine technologies market are the lack of proper insurance and strict regulatory framework governing this industry.

Currently, North America and Europe are leading the global telemedicine technologies market. This is due to the elevated acceptance of telemedicine technologies in these regions. In addition to this, the presence of enhanced healthcare and IT infrastructure promotes the adoption of telemedicine technologies.

Expected Developments in the Global Telemedicine Market

The global telemedicine technologies market is expected to grow at a double-digit CAGR during the forecast period of 2010 to 2017. In the coming few years, the improved access to patient care and telehealth technologies reaching new markets is expected to propel the market. Furthermore, with the advent of telemedicine technologies, the number of emergency room visits and hospitalization is expected to reduce drastically. Multiple healthcare providers can communicate with an individual episode of care and centralize all the existing data and streamline data collection via telemedicine technologies. This is expected to reduce the gap between clinician supply and patient demand.

According to market analysts, China, Brazil, India, and Russia will experience a high growth rate in the global telemedicine technologies market in the coming few years. These regions will benefit from their expanding populations and the accelerating incidence of chronic diseases such as asthma, diabetes, and heart failure. Furthermore, increasing healthcare costs and rising awareness of telemedicine in remote locations will also drive these markets.

Get a Sample Copy of the Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3032

Key players in the global telemedicine technologies market are thus focusing on the emerging markets of Russia and Brazil to expand their services. The global telemedicine technologies market is broadly segmented into software, hardware, and services. Some of the most prominent companies in the global telemedicine technologies market are AMD Telemedicine, McKesson Ltd., Philips Healthcare, GE Healthcare, and Cardio Net.

Microbiology Culture Market to exceed US$7.59 bn by 2023, Bacterial Culture Media to Lead Growth

The microbiology culture market has grown significantly in the last few decades in terms of demand in various end-user industries. Academia, clinical research organizations, and commercial end-user industries such as pharmaceutical, cosmetics, and food and beverage are providing impetus to the global microbiology culture market. The increasing potential of bioprocessing and biopharmaceutical applications has driven demand for microbiology culture media products.

The microbiology culture media market is witnessing strong growth due to factors such as increasing food concerns worldwide, rising number of food product recalls, and growing impact of press coverage on food processing industries. The bacterial culture media segment accounted for the larger share of the global microbiology culture market in 2014. Moreover, the segment is likely to continue its dominance during the forecast period from 2015 to 2023 due to expected rise in application in food microbiology, pharmaceutical microbiology, and disease research. In terms of culture media, the complex media segment held the largest share of the global microbiology culture market in 2014, followed by other market segments such as synthetic media, special media and simple media. Demand for complex media is likely to witness continuous growth during the forecast period as it provides full range of growth factors required to cultivate unknown bacteria or bacteria with complex nutritional requirements. Additionally, demand for ready-to-use, off the shelf products in dehydrated and prepared culture media has increased significantly. This is expected to propel the segment in the near future.

Microbiology culture is the process of culturing microbiological organisms, wherein microorganisms are allowed to reproduce and multiply (grow in number) in a predetermined culture media and controlled laboratory conditions. Various culture methods with a vast range of culture media have been developed for the identification and characterization of microorganisms and are increasingly being used across the world. Presently, these microbiology cultures are used by microbiologists on a large scale in food, beverages, pharmaceuticals, research, cosmetics, and several other industries.

Key factors driving the global microbiology culture market are high demand for improved antibiotics, increasing food microbiology, rising life science research funding, and high prevalence of foodborne and other infectious diseases. 

Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3232

Moreover, the microbiology culture market is witnessing strong growth due to rising food safety concerns, increasing number of food recalls, evolving pathogens, growing press coverage and public awareness, and increasing demand in other industries. Additionally, the industry is expected to expand at a rapid rate due to increased food sourcing due to rise in global food demand and supply. This, in turn, would require advanced culture methods and media for fast and accurate microbial analysis. Microbiology culture methods are the principal diagnostic methods used to determine the cause of infectious diseases by culturing the pathogen in a preset medium.

Read more: http://www.transparencymarketresearch.com/microbiology-culture-market.html

Population Health Management Solutions - How it works?

The terminology population health is defined as the outcome of health analyzed in a group of individuals. These groups are often geographic population such as communities or nations, but they also refer to groups such as disabled persons, ethnic groups, employer groups, prisoners and any other groups. This approach aims at improving the health of entire human population as health outcome of such groups is of relevance to policy makers in both public and private sectors. The landscape of healthcare industry is rapidly changing and patients clinical needs and delivery models have become complex. Thus, for providing better clinical care doctors, nurses, physicians, government bodies, employers and others are increasing adopting patient health management solutions across the globe. The introduction of patient health management solutions enable improved healthcare quality with reduced cost.

Aging population, technological advancements and improved demand for quality life and health are
the key factors that are anticipated to increase the market size of population health management solutions. Rising number of chronically ill patients and increasing focus on reduction of healthcare expenditure across the globe would also stimulate the demand for population health management solutions. However, lack of skilled labor especially in developing countries, huge investments and security of patient’s data are the key reasons that might impede the growth of this market.


Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4174

The population health management solutions market is highly fragmented hence intense competitive rivalry is witnessed among the players. Major players operating in this market are focusing on growth strategies such as mergers and acquisitions, agreements, collaborations, partnerships, innovations, marketing campaign and other promotional activities as to increase their market share. The prominent players operating in population health management solutions market includes. Cerner Corporation, Allscripts Healthcare Solutions, Inc., Explorys, Inc., Conifer Health Solutions, LLC, Healthagen, LLC. (A Subsidiary of Aetna, Inc.), Health Catalyst, LLC, Phytel, Inc., I2i Systems, Inc., Mckesson Corporation, Verisk Health, Inc., Wellcentive, Inc. and other major players. These players dominate the market due to innovative and highly effective products.

Rapidly Growing Geriatric Population to Boost Bone Morphogenetic Proteins Market Valuation to US$587.069 mn by 2022

Bone morphogenetic proteins (BMP) are naturally occurring proteins found in the human body. Identified in 1965 by Marshall Urist, bone morphogenetic proteins are among the most potent growth factors that induce mesenchymal stem cells to differentiate into osteoblast cells. Twenty different types of BMPs have been discovered to date; only BMP 2, 7 and 9 have osteoinductive property and have been proven to play a significant role in bone formation. However, of these, only BMP-2 and BMP-7 are commercially available. These proteins trigger intracellular signal pathways by binding to the receptor of the mesenchymal stem cells resulting in transformation of stem cells into tissue specific progenitor cells. These cells are involved in the synthesis of musculoskeletal tissue formation, extracellular growth and matrix.

The bone morphogenetic proteins market report studies the current scenario as well as future market potential for bone morphogenetic proteins globally. The market overview section of the report comprises qualitative analysis of the overall bone morphogenetic proteins market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s Five Forces analysis and market attractiveness analysis. In addition, various analyses such as event regulatory scenario and value chain analysis have also been provided. Value chain analysis includes the study of major steps involved in the recombinant bone morphogenetic proteins preparation and distribution. Regulatory scenario includes the study of different regulatory norms and procedures that regulate the approval and commercialization of recombinant bone morphogenetic proteins products.

Request a Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2308

Bone morphogenetic proteins (BMPs) that are classified under transforming growth factor beta superfamily are multifactorial growth factors. These are naturally occurring proteins found in the human body, involved in numerous cellular responses. BMPs were first isolated in 1965 by scientist Marshall Urist for the ability to induce the formation of bone and cartilage. To date over 15 BMPs have been isolated and cloned. However, only BMP-2 and BMP-7 are considered to show the greatest amount of osteoinductive potential. Both the types of BMPs share similar kind of cell receptors (Type 1 and Type 2 BMP receptor) that help in regulating bone growth. Thus, for clinical use, BMPs are produced through recombinant DNA technology namely rhBMP-2 and rhBMP-7. These BMPs have been approved by the FDA for use in orthopedic applications such as spinal fusions, oral surgery, and tibia non-unions. These proteins posses the ability to induce patients own cells for bone formation.

In addition, BMPs have proved to be beneficial for patients undergoing spinal fusion surgery by eliminating the need for bone harvesting from the pelvis region. This innovative research approach also reduces the amount of pain, dependence on spinal rods or screws, and augments the rate of spinal fusion. Although, BMPs have proved to be a noteworthy bone graft substitute in spinal fusion, a variety of complications are associated with its off-label usage. Uncontrolled bone formation, bone overgrowth, male sterility, leg pain, back pain, respiratory complication, and inflammation are some of the side effects associated with the implant of BMPs. Thus, the market for BMPs has been restricted by biocompatibility issues, high cost, strict regulations, and presence of numerous bone graft substitutes.

In terms of regional distribution, North America currently accounts for the largest share of the bone morphogenetic proteins market, followed by Europe. Furthermore, North America, with a market share of over 70%, is expected to dominate the industry during the forecast period. This leadership would be witnessed due to high awareness about BMP products, availability of premium priced recombinant BMP products, and soaring number of spinal fusion procedures. Furthermore, highest growth of this industry is expected to emerge in Asia Pacific during the forecast period. The global bone morphogenetic proteins market is characterized by three players namely Medtronic plc, Olympus Biotech, and Cellumed.

Know more: http://www.transparencymarketresearch.com/bone-morphogenetic-protein-market.html

Prevention is Getting Easier with Veterinary Antiseptics

Hydrogen peroxide as an antiseptic is commonly used for the treatment and removal of pus and debris from the wound due to its harsh characteristics. Hydrogen peroxide is also used for cleaning fish ponds, animal water reservoirs, and cages. Alcohol, due to its rapid evaporation action, is less preferred over chlorhexidine and iodine and iodophors based antiseptics. Moreover, several studies have illustrated that alcohol induces bacterial regrowth in wounds. The other products segment includes silver compounds and acetic acid. Silver compounds are used as mild antiseptics and in ophthalmic preparations. Silver nitrate, commonly used as a caustic antiseptic and an astringent, is mostly used in cats and dogs. The degree of action for silver nitrate depends upon the concentration used and the duration for which the compound is allowed to act. Acetic acid is majorly used as wound dressing and in urinary tract irrigation.

Request a Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=6448

Chlorhexidine is widely known for its antiseptic activity in oral care. It is relatively non-irritating to tissues and is used as a bactericidal, virucidal, and fungicidal. Chlorhexidine has limited activity against fungi and mycobacterium. Chlorhexidine as an antiseptic is widely used among horses, cats, sheep, cows, poultry animals, and dogs for the treatment of superficial cuts, abrasions, and insect stings. The potential disadvantages of chlorhexidine include staining of pellicle, unpleasant taste, and desensitized taste buds. Therefore, it is the second leading product in emerging and developing markets. Hydrogen peroxide is a harsh antiseptic agent and can damage the healthy tissues around the wound or abrasion. Despite this characteristic, hydrogen peroxide is an excellent germicidal agent majorly used to remove pus and debris from the wound. Apart from the direct application of hydrogen peroxide on animals, it is used to clean cages, fish ponds, and animal fur.

In dogs, hydrogen peroxide is used to induce vomiting in case of toxic ingestion apart from the prevention of septic. The veterinary antiseptic industry is witnessing impressive growth due to rising demand for animal food products and increasing adoption of companion animals such as cat and dogs. Furthermore, changing lifestyle in developing countries such as China and India has resulted in an increased adoption of pet animals. This is driving the animal health care market in the region. The study of the veterinary antiseptic market in these regions offers a comprehensive understanding of various antiseptic products, injuries therapies, animal welfare laws, animal statistics, marketing and branding strategies, and other core factors of the market.

The study comprises a detailed analysis of the antiseptic products, and helps in understanding various drivers contributing to the market growth in real-time and in the near future. Furthermore, the study focuses on the best practices in animal care, the science behind antiseptic and healing wounds, and the currently prevalent standards of practice in the region. Moreover, the research includes an in-depth competitive analysis and a market model in terms of competitive strategy and current market share. The stakeholders of this report include manufacturers of antiseptic products, wound and injury care products, and companies involved in the distribution of various products such as spirit, alcohol and chlorhexidine and new entrants who wish to enter the market.

Know more: http://www.transparencymarketresearch.com/veterinary-antiseptics-market.html